Merck Serono and Pfizer are to work with the Broad Institute in Cambridge, Massachusetts to undertake genomic profiling of Systemic Lupus Erythematosus (SLE) and Lupus Nephritis (LN) patients.

Dr Reddy's, Merck Serono in pact to develop biotech drugs ... investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write ...

In Europe and Canada, where the drug is marketed by Geneva-based Merck Serono and Serono of Mississauga ... after several cases of hemolytic anemia and again, in October 2008, following the ...